INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
MHRA is harvesting genetic data—here’s why it’s a complete waste of time

MHRA is harvesting genetic data—here’s why it’s a complete waste of time

The Genes-are-Destiny model is broken

Hedley Rees's avatar
Hedley Rees
Jun 01, 2023
∙ Paid
24

Share this post

INSIDE PHARMA
INSIDE PHARMA
MHRA is harvesting genetic data—here’s why it’s a complete waste of time
9
3
Share

MHRA sets up its very own Biobank

Yes, it’s true, UKs MHRA has set up a biobank and this is what it’s all about:

About Yellow Card biobank

Yellow Card biobank is a collaboration between the MHRA and Genomics England. Its goal is to improve understanding of how a patient’s genetic makeup may increase their risk of harm from side effects.

By collecting genetic samples from patients who have experienced suspected side effects, the Yellow Card biobank will create a repository of genetic information that can be used to help determine whether a suspected side effect was caused by a specific genetic trait.

It is hoped the research generated from this resource will enable development of interventions such as screening tests for patients that can be used by healthcare professionals to personalise medical treatment to individuals, according to their genetics. For example, more information about how people with a certain genetic make-up have responded to medicines in the past, will enable healthcare …

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share